Introduction
Cyclin F is a key component of the ubiquitin proteasomal system (UPS), involved in mediating the transfer of ubiquitin molecules to specific substrates, thereby tagging them for degradation by the proteasome. By regulating the degradation and consequently the expression levels of specific substrates through the UPS, cyclin F governs DNA repair and replication and controls cell cycle progression [1] . Dysfunction of cyclin F and a subsequent dysregulation of these pathways have been linked to various forms of cancer [2] [3] [4] . Additionally, mutations in CCNF have recently been reported in two clinically, pathologically and genetically linked neurodegenerative diseases-amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) [5] . To date, only one in vivo model has been established as a tool to investigate CCNF dysfunction-a zebrafish model that transiently overexpressed an ALS-FTD mutation in CCNF (CCNF S621G) [6] . This model demonstrated neurological defects associated with expression of CCNF S621G, including a motor axonopathy and impaired motor function. To supplement the existing transient models, this study aimed to use the Tol2 transposase system [7] to develop zebrafish models that constitutively expressed fluorescently labelled human CCNF under a quasi-ubiquitous (actb2) promoter.
Objective
To develop novel transgenic zebrafish models that constitutively overexpress CCNFfluorophore fusion for use in studies investigating disease-associated dysfunction of this gene. 
Results & Discussion
No founders were identified in the CCNF injected groups Offspring from 102 fish injected with a CCNF construct (32 Hsa.CCNF WT, 28 Hsa.CCNF S621G, 18 ccnf WT and 24 ccnf S6213G) were screened and no founders were identified. Offspring from 8 fish injected with the mCherry control construct were screened and 4 founders were identified (Fig. 1A) . The efficiency of transgenic integration in the mCherry control line, (reported at 30-50% for Tol2 system [8] ) validated the injection and screening methods and suggested a gene-specific issue caused the failure to identify CCNF founders. CCNF expression is lost over the first 6 days of development To investigate this failure, the embryonic injections were repeated, and the screening protocol was altered. Instead of the standard screening at 2-3 days post fertilisation (dpf), screening was performed at 24 h post fertilisation (hpf) followed by subsequent analysis every 24 h up to 6 dpf. A dramatic loss of mCherry expression was observed in all CCNF -injected fish over this time period. In comparison, an increase in the number of mCherry positive cells was evident in the mCherry control fish (Fig. 1B) . To quantify this, the number of mCherry positive cells in 10 fish from each injection group was estimated. This demonstrated no significant difference in the number of mCherry expressing cells between any of the injection groups at 24 hpf (p=0.08). However, significantly more mCherry positive cells were detectable in the control fish than any of the CCNF groups by 2 dpf (p<0.0001) and this difference increased over the next 5 days (Fig. 1C) . Similar loss of expression was seen between mCherry and EGFP fused CCNF To eliminate an unexpected toxicity associated with mCherry fusion to CCNF, mCherry was substituted with the EGFP fluorophore in the Hsa. CCNF WT and ccnf WT constructs. Quantification of the number of fluorophore positive cells in 5 fish in each injection group demonstrated a similar loss of expression between the mCherry and the EGFP groups over the first 6 days of development (Fig. 1D) . Higher levels of cell death were evident in CCNF injected groups compared to mCherry controls To investigate the mechanism responsible for the loss of cells expressing the transgene, cell death was assessed at the time of peak mCherry-CCNF expression (24 hpf) using acridine orange (AO). This analysis demonstrated significantly higher levels of cell death in all of the CCNF groups compared to sham injected controls (p<0.05). No significant difference was seen between any of the CCNF groups (n=30 per group) (Fig. 1E) . Cells that both expressed mCherry fused CCNF and stained positive with AO were observed (Fig. 1F) . This AO staining assay suggests that toxicity associated with overexpression of CCNF is an impediment to establishing transgenic lines based on this gene. It is possible that all, or the majority, of cells in which the CCNF transgene is integrated into the genome, including germline cells, undergoes apoptosis, precluding germline transmission. Given the high level of programmed cell death that occurs during early development [9] and the regenerative capacity of the zebrafish, this CCNF -associated cell death could occur without causing detectable morphological abnormalities.
Conclusions
This study demonstrates that the development of zebrafish transgenic lines that constitutively overexpress CCNF-fluorophore fusions using the described methods is not a feasible option, despite the clearly possible expression of the full-length ORF of the transgenic construct as apparent by fluorescence signal. The authors, therefore, suggest that levels of transgene expression to be re-assessed at 6-7 dpf to detect potential toxic overexpression effects at this early stage. In addition, models with temporal control of transgene expression to bypass overexpression during this period of development and cell death may be warranted.
Limitations
One limitation of this study is that fluorophore fusion proteins were used instead of the native CCNF ORF. For a possible follow-up, a native CCNF ORF could be tested with a transgenesis reporter in cis (i.e. myl7:EGFP or alpha-crystallin:Venus) to uncouple transgene detection from CCNF. In addition, studies to further investigate the failure to establish CCNF transgenic lines could be performed. For example, DNA could be extracted from embryos at 24 hpf to confirm transgenic integration, then repeated at later timepoints to establish whether cells that successfully integrate CCNF survive and to confirm if the loss of expressed CCNF is at a protein or DNA level. The presence of integrated CCNF DNA may assist in the elucidation of any gene silencing effects in the model. The role of CCNF in regulating the cell cycle provides a possible explanation for the apparent toxicity of CCNF overexpression in the embryonic zebrafish. The cell cycle is highly regulated and the coordination of transcription, cell proliferation, migration, differentiation and apoptosis is essential for embryonic development [9] [12] . It is feasible that disruption to this highly regulated system associated with overexpression of CCNF in an organism undergoing rapid cell replication would have toxic effects. It is likely that the toxicity reported here extends beyond CCNF. There is the potential for toxicity to arise when overexpression is introduced into a system and this is of importance during early development when vital systems such as the nervous system are being established. In particular, the generation of models of ALS (and likely most neurodegenerative diseases) may be fraught with difficulties as many of these genes are ubiquitously expressed during development before becoming restricted to the central nervous system [6] [13] . This suggests that the toxicity detailed here is not specific to CCNF expression during developmental stages and may be a factor in the establishment of other models. To overcome this problem, we hypothesise that inducible transgenic lines, that allow for precise temporal control of gene expression will be necessary for the generation of novel models of ALS. The adoption of inducible transgenic lines such as the heat shock-inducible Cre line [14] [15] and Tet-on transgenic lines for doxycycline-inducible gene expression [16] will be crucial in establishing zebrafish models of ALS. Use of such lines will allow for temporal control of CCNF (or other ALS-linked genes) expression to be delayed until the fish matures beyond the developmental stage. We believe that this delay in expression will avoid the issues of early cell toxicity and allow for stable integration of the transgene in the germline, which in turn will facilitate transmission of transgene to the next generation. This would ultimately permit the development of transgenic overexpression CCNF-based zebrafish models of ALS. These inducible models are currently being generated and it is hoped that these models will yield insights into the biological mechanisms causing ALS as well as providing a platform for testing future therapeutics.
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